Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maha Hussain

Showing results (1-10 of 213) with videos related to

Pageof 22
Sort By:
Drugs|June 23, 2009
Management of bladder cancer: current and emerging strategiesNeeraj Agarwal, Maha Hussain
Current Treatment Options in Oncology|January 8, 2014
Intermittent androgen deprivation therapy in advanced prostate cancerAjjai Alva, Maha Hussain
Nature Reviews. Urology|May 21, 2014
Bladder cancer: bladder preservation--learning what we don't knowMaha Hussain, Dan Theodorescu
Critical Reviews in Oncology/Hematology|May 15, 2002
The evolving role of systemic therapy in high risk prostate cancer: strategies for cure in the 21st centuryUlka Vaishampayan, Maha Hussain
Cancer Journal (Sudbury, Mass.)|January 23, 2013
The changing natural history of metastatic prostate cancerAjjai Alva, Maha Hussain
Hematology/Oncology Clinics of North America|November 6, 2013
Management of hormone-sensitive metastatic prostate cancerNeeraj Agarwal, Maha Hussain
Drugs|August 21, 2013
Optimal pharmacotherapeutic management of hormone-sensitive metastatic prostate cancerAjjai Alva, Maha Hussain
Expert Review of Anticancer Therapy|February 19, 2008
Update in systemic therapy of prostate cancer: improvement in quality and duration of lifeUlka Vaishampayan, Maha Hussain
Cancer Chemotherapy and Pharmacology|November 8, 2005
Chemotherapy for prostate cancer: implementing early systemic therapy to improve outcomesGary R Macvicar, Maha Hussain
Current Opinion in Urology|August 22, 2017
Risk stratification in oligometastatic prostate cancer: where are we and what do we need?Alicia K Morgans, Maha Hussain
Pageof 22

Showing results (1-10 of 213) with videos related to

Sort By:
Pageof 22
Drugs|June 23, 2009
Management of bladder cancer: current and emerging strategiesNeeraj Agarwal, Maha Hussain
Current Treatment Options in Oncology|January 8, 2014
Intermittent androgen deprivation therapy in advanced prostate cancerAjjai Alva, Maha Hussain
Nature Reviews. Urology|May 21, 2014
Bladder cancer: bladder preservation--learning what we don't knowMaha Hussain, Dan Theodorescu
Critical Reviews in Oncology/Hematology|May 15, 2002
The evolving role of systemic therapy in high risk prostate cancer: strategies for cure in the 21st centuryUlka Vaishampayan, Maha Hussain
Cancer Journal (Sudbury, Mass.)|January 23, 2013
The changing natural history of metastatic prostate cancerAjjai Alva, Maha Hussain
Hematology/Oncology Clinics of North America|November 6, 2013
Management of hormone-sensitive metastatic prostate cancerNeeraj Agarwal, Maha Hussain
Drugs|August 21, 2013
Optimal pharmacotherapeutic management of hormone-sensitive metastatic prostate cancerAjjai Alva, Maha Hussain
Expert Review of Anticancer Therapy|February 19, 2008
Update in systemic therapy of prostate cancer: improvement in quality and duration of lifeUlka Vaishampayan, Maha Hussain
Cancer Chemotherapy and Pharmacology|November 8, 2005
Chemotherapy for prostate cancer: implementing early systemic therapy to improve outcomesGary R Macvicar, Maha Hussain
Current Opinion in Urology|August 22, 2017
Risk stratification in oligometastatic prostate cancer: where are we and what do we need?Alicia K Morgans, Maha Hussain
Pageof 22